Investor Anthony Scaramucci said Wall Street may be ruthless, but Washington politics is even worse, arguing that finance professionals attack people openly while political insiders work behind the scenes to take people down.
Wall Street Vs. Washington
Scaramucci didn’t elaborate further, but the comment appeared to reference the political and media backlash Musk has faced following his involvement in government reform efforts, his ties to the Department of Government Efficiency initiative and his increasingly outspoken political views.
Don’t Miss:
Scaramucci, who famously spent just 11 days as White House communications director in 2017, said he quickly learned how political power works behind the scenes.
He recalled giving a press conference from the White House shortly after taking the role. Afterward, he said a political ally called him with a warning.
“He said, ‘What the hell are you doing?’” Scaramucci said on the podcast. “I said, ‘What do you mean?’ He said, ‘You can’t talk like that from the White House. You’re talking directly to the American people.’”
According to Scaramucci, establishment figures in Washington immediately moved against him.
“We’ve got Republican senators asking me for opposition research on you,” he recalled being told. “Get this guy out of here.”
Trending: What If Your Investment Income Didn’t Rely Entirely on Market Swings? Some Investors Are Taking a Different Approach
Inflation And The Shrinking American Dream
The conversation focused heavily on economic anxiety in the U.S. and the growing divide between wealthy Americans and working-class families.
Scaramucci said that inflation has quietly devastated people who rely on wages instead of assets.
“You just stole 30% of his life,” he said on the podcast while discussing the decline in purchasing power for hourly workers since 2020.
He pointed to housing affordability as one of the clearest examples of the problem.
According to Scaramucci, the median U.S. home price now sits around $432,000, while the income needed to comfortably afford that home is roughly $160,000. Meanwhile, median household income, he said, is $84,000.
“That means half of the people in the United States, they can’t afford that house,” he said.
See Also: 1.5M+ Users. $29M Raised. Pre-IPO Shares Still at $0.72 — Learn How to Invest Before the Deadline
From Blue-Collar Roots To Wall Street
He described his father as a hardworking laborer whose income rose and fell depending on the economy. During tougher periods, the family adjusted spending accordingly.
“I did not grow up poor,” Scaramucci said. “I would never dishonor my dad by telling anybody I grew up poor.”
Still, he said the American dream has become harder for families like the one he grew up in.
“We turned many of those families into blue-collar desperational in about 40 years,” he said.
Scaramucci also reflected on entering the world of elite finance as a young Harvard Law School graduate who felt completely out of place.
He recalled being told by a Goldman Sachs (NYSE:GS) partner that he was “the worst dressed person” the executive had ever seen during an early job interview because he showed up wearing a cheap polyester suit.
“I had to go to J. Press, which is like a super WASP place,” he said on the podcast. “I got myself one of those student credit cards because I didn’t have any money. And I bought myself two cotton shirts, a woolen suit, and then I went down to Goldman and did the interview again.”
Read Next: Investors Are Racing to Back This Lithium Breakthrough — Don’t Miss the Next Big Energy Boom
Building Wealth Across More Than Just the Market
Rad AI
Immersed
Connect Invest
rHealth
rHealth is building a space-tested diagnostics platform designed to bring lab-quality blood testing closer to patients in minutes rather than weeks. Originally validated in collaboration with NASA for use aboard the International Space Station, the technology is now being adapted for at-home and point-of-care settings to address widespread delays in diagnostic access.
Backed by institutions including NASA and the NIH, rHealth is targeting the large global diagnostics market with a multi-test platform and a model built around devices, consumables, and software. With FDA registration in progress, the company is positioning itself as a potential shift toward faster, more decentralized healthcare testing.
Arrived
Masterworks
Lightstone
AdviserMatch
Accredited Debt Relief
Image: Shutterstock